Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,964
Out of 5,043 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $5.80 | -79.31% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $1.24 | +38,609.68% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $9,000,000 | $8.35 | +107,784,331.14% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $13.00 | +17,207.69% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $81.24 | +158.49% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $5.80
Upside: -79.31%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $1.24
Upside: +38,609.68%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $9,000,000
Current: $8.35
Upside: +107,784,331.14%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $13.00
Upside: +17,207.69%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $81.24
Upside: +158.49%